Elevated expression of CDK4 in lung cancer
暂无分享,去创建一个
Zhen Liu | Jinsong Guo | Yan Zhen | Bin Wu | Huiling Yang | Zhen Liu | W. Fang | Weiyi Fang | Bin Wu | Y. Zhen | Huiling Yang | Aibing Wu | Weiren Luo | Dong Wu | Xiaoli Yu | Hao Wang | Ying Zhou | Zhixiong Yang | Dong Wu | Xiao-li Yu | Ying Zhou | Weiren Luo | Aibing Wu | Zhi-Xiong Yang | Hao Wang | Jinsong Guo
[1] S. Poomsawat,et al. Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. , 2010, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[2] M. Beckmann,et al. Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. , 1999, The American journal of pathology.
[3] R. Kratzke,et al. Inhibition of both mesothelioma cell growth and Cdk4 activity following treatment with a TATp16INK4a peptide. , 2008, Anticancer research.
[4] G. Schneider,et al. Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL‐induced apoptosis via downregulation of survivin , 2007, International journal of cancer.
[5] M. Ghazizadeh,et al. Role of cdk4, p16INK4, and Rb Expression in the Prognosis of Bronchioloalveolar Carcinomas , 2005, Respiration.
[6] C. Conti,et al. Enhanced malignant tumorigenesis in Cdk4 transgenic mice , 2004, Oncogene.
[7] J. Slingerland,et al. Phosphorylation of p27Kip1 Regulates Assembly and Activation of Cyclin D1-Cdk4 , 2008, Molecular and Cellular Biology.
[8] M. Fukayama,et al. Overexpression of cdk4/cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung carcinoma , 2004, International journal of cancer.
[9] T. Shibata,et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics , 2010, Modern Pathology.
[10] Zhen Liu,et al. Decreased expression of updated NESG1 in nasopharyngeal carcinoma: Its potential role and preliminarily functional mechanism , 2011, International journal of cancer.
[11] C. Conti,et al. Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation. , 2002, The American journal of pathology.
[12] S. Knuutila,et al. CDK4 is a probable target gene in a novel amplicon at 12q13.3–q14.1 in lung cancer , 2005, Genes, chromosomes & cancer.
[13] Houwen Li. State of the art:lung cancer in China. , 2003, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[14] Yingdong Zhao,et al. Journal of Translational Medicine Transcriptional Patterns, Biomarkers and Pathways Characterizing Nasopharyngeal Carcinoma of Southern China , 2008 .
[15] M. Tachibana,et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] G. Åkerström,et al. Cyclin-Dependent Kinase 4 (CDK4) Expression in Pancreatic Endocrine Tumors , 2007, Neuroendocrinology.
[17] E. Knudsen,et al. Cyclin-dependent kinase 4/6 activity is a critical determinant of pre-replication complex assembly , 2008, Oncogene.
[18] G. Jianhua,et al. A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers. , 1998, Cancer letters.
[19] M. Mi,et al. BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model. , 2008, International journal of oncology.
[20] Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss. , 2010, Cancer research.